Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Insulin-containing product - Important Safety Information from Sanofi-aventis Ireland Ltd. T/A SANOFI, Eli Lilly and Company Limited and Novo Nordisk Ltd. as approved by the HPRA
Notice type:
3rd Party Publications
Date:
20/09/2018
Problem Or Issue:
Important Safety Information communication from Sanofi-aventis Ireland Ltd. T/A SANOFI, Eli Lilly and Company Limited and Novo Nordisk Ltd: Risk of medication errors associated with extraction of insulin-containing product from cartridges and pre-filled pens.
Important Safety Information - insulin-containing product (HCP)
Important Safety Information - insulin-containing product (Patient)
« Back
Date Printed: 26/04/2024